The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression two years after discontinuing treatment, ...
Dec 18, 2023
0
2
Through a highly collaborative research effort led by the laboratory of Saïd Sebti, Ph.D, at the VCU Massey Comprehensive Cancer Center, a team of scientists has successfully developed a targeted therapy that hones in on ...
Dec 18, 2023
0
1
A new treatment strategy for locally advanced liver cancer, known as "reduce and remove," was announced by the Department of Surgery and Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, ...
Dec 14, 2023
0
35
Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells—an approach known as "cell-based therapy," which uses specially designed T cells to fight ...
Dec 13, 2023
0
0
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver cancer in the U.S. this year, and about 29,000 will die from the disease, according ...
Dec 13, 2023
0
0
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
0
People living in less populated, rural or remote areas are missing out on last-ditch but potentially life-saving cancer clinical trials, according to a recent study by a University of Alberta oncologist that puts the onus ...
Dec 12, 2023
0
0
Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.
Dec 12, 2023
0
47
Non-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine ...
Dec 11, 2023
0
0
A new review paper titled "Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review" has been published in Oncotarget.
Dec 11, 2023
0
0
